“COVID-19 has highlighted an important lesson for fighting cancer: The most advanced tools won’t help if they aren’t deployed widely in clinical settings.” -AI Technology Insights
The pandemic uncovered various inefficiencies in healthcare. We’ve been witness to a national shortage of personal protective equipment, racial minorities and lower-income Americans facing more exposure to public health threats, and shortcomings in vaccination distribution. This past year challenged healthcare professionals and organizations to improve quality of care for every individual.
In response to these weaknesses in the medical community, leading providers and stakeholders are turning to Big Data technologies with Artificial Intelligence (AI) and Natural Language Processing (NLP) capabilities. An investment in advanced, reliable, and comprehensive technology is an investment in patient care. Researchers and physicians are deploying critical new tools to accelerate vaccination rollout and allocate resources to high-risk individuals first and foremost; AI solutions are also being increasingly deployed in oncology to combat setbacks and challenges in cancer clinical trials.
In this article from AI Technology Insights and Kirk Junker, Vice President of Product and Engineering at Inteliquet™, you can learn more about COVID-19 effects, digital technologies, the widespread use of big data, and more.